We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+1.67%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$163M
AUM Growth
-$6.83M
Cap. Flow
-$37.1M
Cap. Flow %
-22.75%
Top 10 Hldgs %
30.94%
Holding
192
New
47
Increased
35
Reduced
23
Closed
17

Top Buys

Rank Stock Value
1
ADTN icon
Adtran
ADTN
+$6.46M
2
INDI icon
indie Semiconductor
INDI
+$2.74M
3
SILC icon
Silicom
SILC
+$2.7M
4
SEV
Sono Group N.V. Common Shares
SEV
+$2.6M
5
TELA icon
TELA Bio
TELA
+$2.22M

Top Sells

Rank Stock Value
1
CYBE
Cyberoptics Corp
CYBE
+$3.74M
2
CTO
CTO Realty Growth
CTO
+$865K
3
SCPH
scPharmaceuticals
SCPH
+$788K
4
ATEN icon
A10 Networks
ATEN
+$680K
5
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$640K

Sector Composition

Rank Sector Weight
1 Technology 23.41%
2 Healthcare 15.13%
3 Consumer Discretionary 5.61%
4 Financials 5.45%
5 Materials 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLYM
76
DELISTED
Plymouth Industrial REIT
PLYM
$215K 0.13%
12,800
– –
HIW icon
77
Highwoods Properties
HIW
$3.64B
$214K 0.13%
+7,950
New +$257K
HLIT icon
78
Harmonic Inc
HLIT
$1.34B
$203K 0.12%
+15,500
New +$167K
WSR
79
DELISTED
Whitestone REIT
WSR
$202K 0.12%
23,850
– –
PRBM
80
DELISTED
Parabellum Acquisition Corp.
PRBM
$194K 0.12%
39,221
– –
AMPS
81
DELISTED
Altus Power
AMPS
$182K 0.11%
+16,500
New +$157K
SLNO
82
DELISTED
Soleno Therapeutics
SLNO
$176K 0.11%
105,513
-1
-0% -$2
NOK icon
83
Nokia
NOK
$55.5B
$171K 0.1%
40,000
+30,000
+300% +$146K
FLEX icon
84
Flex
FLEX
$46.8B
$167K 0.1%
+13,270
New +$170K
SIRI icon
85
SiriusXM
SIRI
$10.4B
$166K 0.1%
2,905
– –
SQNS
86
Sequans Communications SA
SQNS
$40.7M
$162K 0.1%
1,820
+320
+21% +$26.7K
DEA
87
Easterly Government Properties
DEA
$1.18B
$161K 0.1%
+4,080
New +$189K
CIO
88
DELISTED
City Office REIT
CIO
$160K 0.1%
16,050
– –
MIR icon
89
Mirion Technologies
MIR
$4.03B
$160K 0.1%
+21,381
New +$151K
PCSA icon
90
Processa Pharmaceuticals
PCSA
$6.01M
$160K 0.1%
142
– –
ILCV icon
91
PUT
iShares Morningstar Value ETF
ILCV
$1.35B
$152K 0.09%
30,400
+3,900
+15% +$243K
PGRE
92
DELISTED
Paramount Group
PGRE
$151K 0.09%
24,300
+3,100
+15% +$22.3K
VISN
93
Vistance Networks Inc
VISN
$2.82B
$147K 0.09%
+16,000
New +$153K
CLRB icon
94
Cellectar Biosciences
CLRB
$20.9M
$140K 0.09%
1,388
-139
-9% -$20K
INVE icon
95
Identive
INVE
$64.3M
$138K 0.08%
11,000
+1,000
+10% +$13.7K
LTRX icon
96
Lantronix
LTRX
$273M
$125K 0.08%
26,000
+4,500
+21% +$27.3K
TCDA
97
PUT
DELISTED
Tricida, Inc. Common Stock
TCDA
$123K 0.08%
66,500
+42,700
+179% +$467K
ABEO icon
98
Abeona Therapeutics
ABEO
$389M
$106K 0.06%
34,773
+33,382
+2,400% +$138K
ZETA icon
99
Zeta Global
ZETA
$6.05B
$99K 0.06%
+15,000
New +$92.6K
AVYA
100
PUT
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$99K 0.06%
111,800
+41,400
+59% +$65.7K
2 3
4
5 6

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Worth Venture Partners held 192 positions worth $163M, down 4% from $170M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Worth Venture Partners withdrew a net $37.1M in Q3 2022, closing 17 positions and reducing 23 holdings. Its most notable exit was Cyberoptics Corp, an estimated $3.74M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Worth Venture Partners opened a new position in Adtran worth $5.8M.

  • Worth Venture Partners's largest Q3 2022 buy was Adtran: 296,241 shares worth $5.8M.
  • Worth Venture Partners added most to TELA Bio in Q3 2022, an estimated $2.22M increase.
  • Worth Venture Partners's biggest Q3 2022 reduction was CTO Realty Growth, cutting an estimated $865K.
  • Worth Venture Partners fully exited Cyberoptics Corp in Q3 2022, selling an estimated $3.74M.
  • Worth Venture Partners's ten largest holdings make up 31% of its $163M portfolio in Q3 2022.
  • Worth Venture Partners opened 47 new positions and closed 17 in Q3 2022.
  • Worth Venture Partners's portfolio value fell 4% quarter-over-quarter to $163M.

Based on Worth Venture Partners's 13F filing for Q3 2022, filed 14 Nov 2022.